{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:58:08Z","timestamp":1792173488167,"version":"4.4.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014935","name":"BioCryst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014935","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.waojou.2023.100792","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T23:12:19Z","timestamp":1688080339000},"page":"100792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["The multifactorial impact of receiving a hereditary angioedema diagnosis"],"prefix":"10.1016","volume":"16","author":[{"given":"Jason","family":"Raasch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C","family":"Glaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeve","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaip.2020.08.046","article-title":"US HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema","volume":"9","author":"Busse","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18176\/jiaci.0653","article-title":"Treatment of hereditary angioedema","volume":"31","author":"Caballero","year":"2021","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"7","key":"10.1016\/j.waojou.2023.100792_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.12968\/hmed.2019.80.7.391","article-title":"Hereditary angioedema: an update on causes, manifestations and treatment","volume":"80","author":"Longhurst","year":"2019","journal-title":"Br J Hosp Med"},{"issue":"3","key":"10.1016\/j.waojou.2023.100792_bib4","doi-asserted-by":"crossref","first-page":"100627","DOI":"10.1016\/j.waojou.2022.100627","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema\u2013The 2021 revision and update","volume":"15","author":"Maurer","year":"2022","journal-title":"World Allergy Org J"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/humu.23917","article-title":"SERPING1 mutation update: mutation spectrum and C1 Inhibitor phenotypes","volume":"41","author":"Ponard","year":"2020","journal-title":"Hum Mutat"},{"issue":"9225","key":"10.1016\/j.waojou.2023.100792_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib7","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","article-title":"Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor","volume":"343","author":"Dewald","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.waojou.2023.100792_bib8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jaci.2017.05.020","article-title":"Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema","volume":"141","author":"Bafunno","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2023.100792_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/all.13270","article-title":"Hereditary angioedema with a mutation in the plasminogen gene","volume":"73","author":"Bork","year":"2018","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.waojou.2023.100792_bib10","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/all.13869","article-title":"Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin","volume":"74","author":"Bork","year":"2019","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.waojou.2023.100792_bib11","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1111\/all.14454","article-title":"A\u00a0myoferlin gain-of-function variant associates with a new type of hereditary angioedema","volume":"75","author":"Ariano","year":"2020","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib12","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jaci.2021.01.011","article-title":"Novel hereditary angioedema linked with a heparan sulfate 3-O-sulfotransferase 6 gene mutation","volume":"148","author":"Bork","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-020-1334-8","article-title":"Treatment of patients with hereditary angioedema with the c. 988A> G (p. Lys330Glu) variant in the plasminogen gene","volume":"15","author":"Bork","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.waojou.2023.100792_bib14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ced.12285","article-title":"Characterization of prodromal symptoms in a large population of patients with hereditary angio-oedema","volume":"39","author":"Magerl","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.waojou.2023.100792_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.18176\/jiaci.0102","article-title":"Triggers and prodromal symptoms of angioedema attacks in patients with hereditary angioedema","volume":"26","author":"Caballero","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"5","key":"10.1016\/j.waojou.2023.100792_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2500\/aap.2010.31.3387","article-title":"Current treatment of hereditary angioedema: an update on clinical studies","volume":"31","author":"Banerji","year":"2010","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.waojou.2023.100792_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/jcp.2003.12021","article-title":"Normal complement C4 values do not exclude hereditary angioedema","volume":"57","author":"Karim","year":"2004","journal-title":"J\u00a0Clin Pathol"},{"issue":"3","key":"10.1016\/j.waojou.2023.100792_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2249.2007.03438.x","article-title":"An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema","volume":"149","author":"Tarzi","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"1-2","key":"10.1016\/j.waojou.2023.100792_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jim.2008.06.004","article-title":"Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations","volume":"338","author":"Wagenaar-Bos","year":"2008","journal-title":"J\u00a0Immunol Methods"},{"issue":"15","key":"10.1016\/j.waojou.2023.100792_bib20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.clinbiochem.2017.04.007","article-title":"Complement factor C4 activation in patients with hereditary angioedema","volume":"50","author":"Aabom","year":"2017","journal-title":"Clin Biochem"},{"issue":"3","key":"10.1016\/j.waojou.2023.100792_bib21","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaip.2019.10.004","article-title":"International consensus on the use of genetics in the management of hereditary angioedema","volume":"8","author":"Germenis","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jemermed.2020.09.044","article-title":"Recognition and differential diagnosis of hereditary angioedema in the emergency department","volume":"60","author":"Pines","year":"2021","journal-title":"J\u00a0Emerg Med"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/acem.12341","article-title":"A\u00a0consensus parameter for the evaluation and management of angioedema in the emergency department","volume":"21","author":"Moellman","year":"2014","journal-title":"Acad Emerg Med"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1865-1380-5-39","article-title":"Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema","volume":"5","author":"Bernstein","year":"2012","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.waojou.2023.100792_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13223-020-00437-x","article-title":"Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review","volume":"16","author":"Levy","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.5811\/westjem.2019.5.42650","article-title":"Evaluation and management of angioedema in the emergency department","volume":"20","author":"Long","year":"2019","journal-title":"West J Emerg Med"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-018-0229-4","article-title":"Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey","volume":"8","author":"Zanichelli","year":"2018","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.waojou.2023.100792_bib28","article-title":"Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema","volume":"131","author":"Cao","year":"2021","journal-title":"OceanSide Pub"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib29","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.anai.2016.08.014","article-title":"Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting","volume":"117","author":"Zanichelli","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11-12","key":"10.1016\/j.waojou.2023.100792_bib30","doi-asserted-by":"crossref","first-page":"e765","DOI":"10.1093\/milmed\/usy031","article-title":"Extremely delayed diagnosis of type II hereditary angioedema: case report and review of the literature","volume":"183","author":"Berger","year":"2018","journal-title":"Mil Med"},{"issue":"14 Suppl","key":"10.1016\/j.waojou.2023.100792_bib31","first-page":"S292","article-title":"Severity of hereditary angioedema, prevalence, and diagnostic considerations","volume":"24","author":"Bernstein","year":"2018","journal-title":"Am J Manag Care"},{"issue":"6","key":"10.1016\/j.waojou.2023.100792_bib32","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.anai.2020.02.018","article-title":"Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States","volume":"124","author":"Banerji","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2023.100792_bib33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2147\/TCRM.S86293","article-title":"Diagnosis and screening of patients with hereditary angioedema in primary care","volume":"12","author":"Henao","year":"2016","journal-title":"Therapeut Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1710-1492-9-29","article-title":"Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe","volume":"9","author":"Zanichelli","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib35","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1081-1206(10)61121-0","article-title":"Hereditary angioedema due to C1 inhibitor\u00a0deficiency: patient registry and approach to the prevalence in Spain","volume":"94","author":"Roche","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2023.100792_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.alit.2020.09.008","article-title":"The diagnosis and treatment of hereditary angioedema patients in Japan: a patient reported outcome survey","volume":"70","author":"Iwamoto","year":"2021","journal-title":"Allergol Int"},{"issue":"5","key":"10.1016\/j.waojou.2023.100792_bib37","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1365-2133.2009.09366.x","article-title":"Hereditary angio-oedema in Denmark: a nationwide survey","volume":"161","author":"Bygum","year":"2009","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000366276","article-title":"Hereditary angioedema in Greece: the first results of the Greek hereditary angioedema registry","volume":"164","author":"Psarros","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/cei.12159","article-title":"A\u00a0UK national audit of hereditary and acquired angioedema","volume":"175","author":"Jolles","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2023.100792_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.anai.2009.12.004","article-title":"Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?","volume":"104","author":"Lunn","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3-4","key":"10.1016\/j.waojou.2023.100792_bib41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000488350","article-title":"Clinical features of hereditary\u00a0angioedema in Korean patients: a nationwide multicenter study","volume":"176","author":"Jung","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.anai.2013.05.028","article-title":"Depression and anxiety in patients with hereditary angioedema","volume":"112","author":"Fouche","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.waojou.2023.100792_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260805","article-title":"How do patients and physicians communicate about hereditary angioedema in the United States?","volume":"16","author":"Jain","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.waojou.2023.100792_bib44","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jaci.2012.05.055","article-title":"Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency","volume":"130","author":"Bork","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2023.100792_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1054773818780102","article-title":"The diagnosis of hereditary angioedema: family caregivers' experiences","volume":"29","author":"Granero-Molina","year":"2020","journal-title":"Clin Nurs Res"},{"key":"10.1016\/j.waojou.2023.100792_bib46","first-page":"10","article-title":"Valle SOR, Toledo EC. Hereditary angioedema: a disease seldom diagnosed by pediatricians","volume":"97","author":"RdA","year":"2021","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.waojou.2023.100792_bib47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/all.13001","article-title":"International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency","volume":"72","author":"Farkas","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2023.100792_bib48","article-title":"HAE in children-what is the best treatment strategy? Approval of a Drug","volume":"2","author":"Salguero","year":"2016","journal-title":"Int J Aller Med"},{"issue":"8","key":"10.1016\/j.waojou.2023.100792_bib49","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/pai.13309","article-title":"Hereditary angioedema in children and adolescents\u2013A consensus update on therapeutic strategies for German-speaking countries","volume":"31","author":"Wahn","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib50","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaip.2016.12.033","article-title":"Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients","volume":"5","author":"Busse","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib51","doi-asserted-by":"crossref","first-page":"100621","DOI":"10.1016\/j.waojou.2021.100621","article-title":"Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor","volume":"15","author":"Jones","year":"2022","journal-title":"World Allergy Org J"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-021-00537-2","article-title":"Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report","volume":"17","author":"Bork","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-021-00563-0","article-title":"Psychosocial burden of type 1 and 2 hereditary angioedema: a single-center Canadian cohort study","volume":"17","author":"Hews-Girard","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-021-01717-4","article-title":"Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey","volume":"16","author":"Mendivil","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib55","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2340\/00015555-1743","article-title":"Hereditary angioedema - consequences of a new treatment paradigm in Denmark","volume":"94","author":"Bygum","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2500\/aap.2013.34.3685","article-title":"The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe","volume":"35","author":"Caballero","year":"2014","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.waojou.2023.100792_bib57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12016-016-8575-2","article-title":"The humanistic, societal, and pharmaco-economic burden of angioedema","volume":"51","author":"Longhurst","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-9-99","article-title":"Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe","volume":"9","author":"Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.waojou.2023.100792_bib59","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2500\/aap.2010.31.3394","article-title":"The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression","volume":"31","author":"Lumry","year":"2010","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-018-0307-0","article-title":"The diagnosis of hereditary angioedema with C1 inhibitor deficiency: a survey of Canadian physicians and laboratories","volume":"14","author":"Charest-Morin","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib61","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.anai.2022.01.014","article-title":"A case of normal C1-esterase inhibitor hereditary angioedema successfully treated with berotralstat","volume":"Apr;128","author":"Kelbel","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2023.100792_bib62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fmed.2018.00022","article-title":"Hereditary angioedema: the economics of treatment of an orphan disease","volume":"5","author":"Lumry","year":"2018","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.anai.2010.01.024","article-title":"Economic costs associated with acute attacks and long-term management of hereditary angioedema","volume":"104","author":"Wilson","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2023.100792_bib64","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/cei.12433","article-title":"Paediatric hereditary angioedema: a survey of UK service provision and patient experience","volume":"178","author":"Read","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.waojou.2023.100792_bib65","series-title":"KALBITOR (ecallantide) injection, for subcutaneous use \u2013 prescribing information","year":"2021"},{"key":"10.1016\/j.waojou.2023.100792_bib66","series-title":"ICATIBANT injection, for subcutaneous use \u2013 prescribing information","year":"2022"},{"key":"10.1016\/j.waojou.2023.100792_bib67","series-title":"BERINERT [C1 esterase inhibitor (Human)] for intravenous use. Freeze-dried powder for reconstitution \u2013 prescribing information","year":"2021"},{"key":"10.1016\/j.waojou.2023.100792_bib68","series-title":"For Intravenous Use, Lyophilized Powder For Reconstitution \u2013 prescribing information","article-title":"BV. RUCONEST (C1 esterase inhibitor [recombinant])","author":"Netherlands","year":"2016"},{"key":"10.1016\/j.waojou.2023.100792_bib71","series-title":"CINRYZE (C1 Esterase Inhibitor [Human]). For Intravenous Use, Freeze-Dried Powder for Reconstitution \u2013 prescribing information","year":"2023"},{"key":"10.1016\/j.waojou.2023.100792_bib72","series-title":"HAEGARDA\u00ae (C1 Esterase Inhibitor Subcutaneous [Human]). For Subcutaneous Injection, Freeze-Dried Powder for Reconstitution \u2013 prescribing information","year":"2022"},{"key":"10.1016\/j.waojou.2023.100792_bib73","series-title":"Caregivers' Role in Managing Hereditary Angioedema and Perceptions of Treatment-Related Burden","author":"Craig","year":"2021"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib74","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13023-018-0871-x","article-title":"Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study","volume":"13","author":"Savarese","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.waojou.2023.100792_bib75","first-page":"89","article-title":"Update on treatment of hereditary angioedema","volume":"30","author":"Buyantseva","year":"2012","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"8","key":"10.1016\/j.waojou.2023.100792_bib76","first-page":"1361","article-title":"Clinical review of hereditary angioedema: diagnosis and management","volume":"8","author":"Weis","year":"2021","journal-title":"Ann Hematol Oncol"},{"issue":"3","key":"10.1016\/j.waojou.2023.100792_bib77","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2500\/aap.2015.36.3824","article-title":"Current state of hereditary angioedema management: a patient survey","volume":"36","author":"Banerji","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.waojou.2023.100792_bib78","unstructured":"U.S. Food and Drug Administration (FDA). The Voice of the Patient. Accessed March 31, 2023, https:\/\/www.fda.gov\/files\/about%20fda\/published\/The-Voice-of-the-Patient\u2013-Hereditary-Angioedema.pdf."},{"key":"10.1016\/j.waojou.2023.100792_bib79","series-title":"The Burden of Hospitalizations and Emergency Department Visits with Hereditary Angioedema and Angioedema in the United States","first-page":"2010","author":"Zilberberg","year":"2007"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib80","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000381341","article-title":"Home therapy with plasma-derived C1 inhibitor: a strategy to improve clinical outcomes and costs in hereditary angioedema","volume":"166","author":"Petraroli","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2023.100792_bib81","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.jaip.2019.10.028","article-title":"Burden of emergency department utilization and abdominal imaging for hereditary angioedema","volume":"8","author":"Cheng","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.waojou.2023.100792_bib82","first-page":"203","article-title":"Modeling cost-effectiveness of on-demand treatment for hereditary angioedema attacks","volume":"26","author":"Bernstein","year":"2020","journal-title":"J\u00a0Manage Care Spec Pharm"},{"issue":"6","key":"10.1016\/j.waojou.2023.100792_bib83","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jaci.2021.05.016","article-title":"Consensus on\u00a0treatment goals in hereditary angioedema: a global Delphi\u00a0initiative","volume":"148","author":"Maurer","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2023.100792_bib84","series-title":"2021 AMA Prior Authorization Physician Survey","year":"2021"},{"issue":"3","key":"10.1016\/j.waojou.2023.100792_bib85","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.anai.2020.10.009","article-title":"Current medical management of hereditary angioedema: follow-up survey of US physicians","volume":"126","author":"Riedl","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12245-017-0141-z","article-title":"Angioedema in the emergency department: a practical guide to differential diagnosis and management","volume":"10","author":"Bernstein","year":"2017","journal-title":"Int J Emerg Med"},{"issue":"1","key":"10.1016\/j.waojou.2023.100792_bib87","first-page":"51","article-title":"Hereditary angioedema patients would prefer newer-generation oral prophylaxis","volume":"10","author":"Geba","year":"2021","journal-title":"J\u00a0Drug Asses"},{"key":"10.1016\/j.waojou.2023.100792_bib88","series-title":"Hereditary Angioedema: Epidemiology and Burden of Disease","author":"Lumry","year":"2020"},{"key":"10.1016\/j.waojou.2023.100792_bib89","first-page":"S17","article-title":"Physician and patient perspectives on the management of hereditary angioedema: a survey on treatment burden and needs","author":"Riedl","year":"2021","journal-title":"OceanSide Publications, Inc"},{"key":"10.1016\/j.waojou.2023.100792_bib90","series-title":"Patient Perspectives on the Treatment Burden of Injectable Medication for Hereditary Angioedema","author":"Radojicic","year":"2021"},{"key":"10.1016\/j.waojou.2023.100792_bib91","unstructured":"European Medicines Agency. Summary of opinion: Orladeyo. Accessed August 31, 2021, https:\/\/www.ema.europa.eu\/en\/documents\/smop-initial\/chmp-summary-positive-opinion-orladeyo_en.pdf."},{"key":"10.1016\/j.waojou.2023.100792_bib92","unstructured":"Kerkar P. What is the C1 Esterase Inhibitor Test and Why is it Ordered? Accessed on 24 May 2022., https:\/\/www.epainassist.com\/test-and-procedures\/what-is-the-c1-esterase-inhibitor-test]."}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455123000522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455123000522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:46:32Z","timestamp":1761849992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455123000522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1939455123000522"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2023.100792","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multifactorial impact of receiving a hereditary angioedema diagnosis","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2023.100792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100792"}}